DAGL β Antibodies

Santa Cruz Biotechnology provides a broad selection of DAGL β Antibodies for research in lipid signaling pathways. DAGL β Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DAGL β (diacylglycerol lipase beta) plays a crucial role in the synthesis of endocannabinoids, which regulate various physiological processes, including pain sensation, mood, and appetite. Understanding DAGL β function is essential for elucidating its involvement in neurobiology and potential therapeutic targets for various disorders. DAGL β research has revealed significant insights into cellular signaling mechanisms and their impact on neurological function. Ongoing studies continue to uncover new roles for DAGL β in both normal physiology and disease states. Recent findings highlight DAGL β's importance in synaptic plasticity and neural development. Santa Cruz Biotechnology monoclonal antibodies for DAGL β support researchers worldwide in advancing our understanding of lipid signaling pathways and their therapeutic applications.